UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000019191 |
|---|---|
| Receipt number | R000021559 |
| Scientific Title | Randomized Phase II/III Trial of Conventional Paclitaxel and Carboplatin with/without Bevacizumab versus Dose-dense Paclitaxel and Carboplatin with/without Bevacizumab in Stage IVB, Recurrent, or Persistent Cervical Carcinoma (JCOG1311, CC-TC/ddTC-P2/3) |
| Date of disclosure of the study information | 2015/10/01 |
| Last modified on | 2021/01/05 16:08:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/10/01 10:48:31 | ||
| 2 | Update | 2015/10/07 17:07:40 | Primary outcomes Primary outcomes Key secondary outcomes |
|
| 3 | Update | 2015/10/07 17:13:23 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 4 | Update | 2016/09/12 17:06:10 | Name of primary person or sponsor Organization |
|
| 5 | Update | 2016/09/12 17:07:12 | Recruitment status |
|
| 6 | Update | 2017/07/27 20:46:26 | Public title Public title Acronym Acronym |
|
| 7 | Update | 2017/07/27 20:47:51 | Narrative objectives1 Narrative objectives1 |
|
| 8 | Update | 2017/07/27 20:55:47 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key inclusion criteria |
|
| 9 | Update | 2017/07/28 13:45:19 | Division name Organization Organization Organization Institutions |
|
| 10 | Update | 2017/07/28 14:45:06 | Recruitment status |
|
| 11 | Update | 2021/01/05 16:08:13 | Recruitment status Date of IRB |
